The protective role of RACK1 in hepatic ischemia‒reperfusion injury-induced ferroptosis
- PMID: 39292271
- DOI: 10.1007/s00011-024-01944-y
The protective role of RACK1 in hepatic ischemia‒reperfusion injury-induced ferroptosis
Abstract
Although ferroptosis plays a crucial role in hepatic ischemia‒reperfusion injury (IRI), the molecular mechanisms underlying this process remain unclear. We aimed to explore the potential involvement of the receptor for activated C kinase 1 (RACK1) in hepatic IRI-triggered ferroptosis. Using hepatocyte-specific RACK1 knockout mice and alpha mouse liver 12 (AML12) cells, we conducted a series of in vivo and in vitro experiments. We found that RACK1 has a protective effect on hepatic IRI-induced ferroptosis. Specifically, RACK1 was found to interact with AMPKα through its 1-93 amino acid (aa) region, which facilitates the phosphorylation of AMPKα at threonine 172 (Thr172), ultimately exerting an antiferroptotic effect. Furthermore, the long noncoding RNA (lncRNA) ZNFX1 Antisense 1 (ZFAS1) directly binds to aa 181-317 of RACK1. ZFAS1 has a dual impact on RACK1 by promoting its ubiquitin‒proteasome-mediated degradation and inhibiting its expression at the transcriptional level, which indirectly exacerbates hepatic IRI-induced ferroptosis. These findings underscore the protective role of RACK1 in hepatic IRI-induced ferroptosis and showcase its potential as a prophylactic target for hepatic IRI mitigation.
Keywords: AMPKα; Ferroptosis; Hepatic ischemia‒reperfusion injury; RACK1; ZFAS1.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
The Lactate-Primed KAT8‒PCK2 Axis Exacerbates Hepatic Ferroptosis During Ischemia/Reperfusion Injury by Reprogramming OXSM-Dependent Mitochondrial Fatty Acid Synthesis.Adv Sci (Weinh). 2025 Mar;12(11):e2414141. doi: 10.1002/advs.202414141. Epub 2025 Jan 24. Adv Sci (Weinh). 2025. PMID: 39853940 Free PMC article.
-
Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis.Stem Cell Res Ther. 2022 Jul 15;13(1):297. doi: 10.1186/s13287-022-02986-x. Stem Cell Res Ther. 2022. PMID: 35841017 Free PMC article.
-
Ferroptosis in hepatic ischemia‑reperfusion injury: Regulatory mechanisms and new methods for therapy (Review).Mol Med Rep. 2021 Mar;23(3):225. doi: 10.3892/mmr.2021.11864. Epub 2021 Jan 26. Mol Med Rep. 2021. PMID: 33495834 Review.
-
Mesenchymal Stem Cells Prevent SLC39A14-Dependent Hepatocyte Ferroptosis through Exosomal miR-16-5p in Liver Graft.Adv Sci (Weinh). 2025 Feb;12(6):e2411380. doi: 10.1002/advs.202411380. Epub 2024 Dec 16. Adv Sci (Weinh). 2025. PMID: 39680749 Free PMC article.
-
Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.Int J Mol Sci. 2018 Apr 26;19(5):1302. doi: 10.3390/ijms19051302. Int J Mol Sci. 2018. PMID: 29701719 Free PMC article. Review.
Cited by
-
LncRNA ENSSSCG00000035331 Alleviates Hippocampal Neuronal Ferroptosis and Brain Injury Following Porcine Cardiopulmonary Resuscitation by Regulating the miR-let7a/GPX4 Axis.CNS Neurosci Ther. 2025 Apr;31(4):e70377. doi: 10.1111/cns.70377. CNS Neurosci Ther. 2025. PMID: 40237277 Free PMC article.
-
The role of ferroptosis-related non-coding RNA in liver fibrosis.Front Cell Dev Biol. 2024 Dec 9;12:1517401. doi: 10.3389/fcell.2024.1517401. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39717848 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources